nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP3A7—Progesterone—uterine cancer	0.116	0.164	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.116	0.164	CbGbCtD
Nisoldipine—CYP3A5—Progesterone—uterine cancer	0.0871	0.123	CbGbCtD
Nisoldipine—CYP1A2—Progesterone—uterine cancer	0.0648	0.0917	CbGbCtD
Nisoldipine—ABCB1—Progesterone—uterine cancer	0.0567	0.0802	CbGbCtD
Nisoldipine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0513	0.0725	CbGbCtD
Nisoldipine—ABCB1—Dactinomycin—uterine cancer	0.045	0.0636	CbGbCtD
Nisoldipine—CYP3A5—Etoposide—uterine cancer	0.039	0.0551	CbGbCtD
Nisoldipine—CYP3A4—Progesterone—uterine cancer	0.034	0.048	CbGbCtD
Nisoldipine—CYP1A2—Etoposide—uterine cancer	0.029	0.041	CbGbCtD
Nisoldipine—ABCB1—Etoposide—uterine cancer	0.0254	0.0359	CbGbCtD
Nisoldipine—ABCB1—Doxorubicin—uterine cancer	0.0173	0.0245	CbGbCtD
Nisoldipine—CYP3A4—Etoposide—uterine cancer	0.0152	0.0215	CbGbCtD
Nisoldipine—CYP3A4—Doxorubicin—uterine cancer	0.0104	0.0147	CbGbCtD
Nisoldipine—CACNA1C—myometrium—uterine cancer	0.000515	0.0827	CbGeAlD
Nisoldipine—Colitis—Epirubicin—uterine cancer	0.000492	0.00184	CcSEcCtD
Nisoldipine—Vaginal infection—Epirubicin—uterine cancer	0.000484	0.00181	CcSEcCtD
Nisoldipine—Blood urea increased—Epirubicin—uterine cancer	0.000484	0.00181	CcSEcCtD
Nisoldipine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000476	0.00178	CcSEcCtD
Nisoldipine—Vaginal inflammation—Doxorubicin—uterine cancer	0.000474	0.00177	CcSEcCtD
Nisoldipine—Cramps of lower extremities—Epirubicin—uterine cancer	0.000471	0.00176	CcSEcCtD
Nisoldipine—Myalgia—Dactinomycin—uterine cancer	0.00047	0.00176	CcSEcCtD
Nisoldipine—Hypersensitivity—Progesterone—uterine cancer	0.00047	0.00175	CcSEcCtD
Nisoldipine—Abnormal dreams—Doxorubicin—uterine cancer	0.000469	0.00175	CcSEcCtD
Nisoldipine—Rash maculo-papular—Epirubicin—uterine cancer	0.000466	0.00174	CcSEcCtD
Nisoldipine—Discomfort—Dactinomycin—uterine cancer	0.000465	0.00173	CcSEcCtD
Nisoldipine—Mouth ulceration—Epirubicin—uterine cancer	0.000464	0.00173	CcSEcCtD
Nisoldipine—Ecchymosis—Epirubicin—uterine cancer	0.000464	0.00173	CcSEcCtD
Nisoldipine—Melaena—Doxorubicin—uterine cancer	0.000463	0.00173	CcSEcCtD
Nisoldipine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000459	0.00171	CcSEcCtD
Nisoldipine—Hypoaesthesia—Etoposide—uterine cancer	0.000457	0.00171	CcSEcCtD
Nisoldipine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000457	0.00171	CcSEcCtD
Nisoldipine—Colitis—Doxorubicin—uterine cancer	0.000455	0.0017	CcSEcCtD
Nisoldipine—Pruritus—Progesterone—uterine cancer	0.000451	0.00169	CcSEcCtD
Nisoldipine—Oedema—Dactinomycin—uterine cancer	0.000451	0.00168	CcSEcCtD
Nisoldipine—Hypertonia—Epirubicin—uterine cancer	0.000449	0.00168	CcSEcCtD
Nisoldipine—Vaginal infection—Doxorubicin—uterine cancer	0.000448	0.00167	CcSEcCtD
Nisoldipine—Blood urea increased—Doxorubicin—uterine cancer	0.000448	0.00167	CcSEcCtD
Nisoldipine—Abnormal vision—Epirubicin—uterine cancer	0.000447	0.00167	CcSEcCtD
Nisoldipine—Mental disability—Epirubicin—uterine cancer	0.000445	0.00166	CcSEcCtD
Nisoldipine—Diarrhoea—Progesterone—uterine cancer	0.000436	0.00163	CcSEcCtD
Nisoldipine—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000436	0.00163	CcSEcCtD
Nisoldipine—CACNA1D—uterine cervix—uterine cancer	0.000434	0.0697	CbGeAlD
Nisoldipine—Rash maculo-papular—Doxorubicin—uterine cancer	0.000431	0.00161	CcSEcCtD
Nisoldipine—Anorexia—Dactinomycin—uterine cancer	0.00043	0.0016	CcSEcCtD
Nisoldipine—Ecchymosis—Doxorubicin—uterine cancer	0.000429	0.0016	CcSEcCtD
Nisoldipine—Mouth ulceration—Doxorubicin—uterine cancer	0.000429	0.0016	CcSEcCtD
Nisoldipine—Diabetes mellitus—Epirubicin—uterine cancer	0.000428	0.0016	CcSEcCtD
Nisoldipine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000426	0.00159	CcSEcCtD
Nisoldipine—Dizziness—Progesterone—uterine cancer	0.000422	0.00157	CcSEcCtD
Nisoldipine—Hypertonia—Doxorubicin—uterine cancer	0.000416	0.00155	CcSEcCtD
Nisoldipine—Abnormal vision—Doxorubicin—uterine cancer	0.000414	0.00154	CcSEcCtD
Nisoldipine—Chills—Etoposide—uterine cancer	0.000412	0.00154	CcSEcCtD
Nisoldipine—Mental disability—Doxorubicin—uterine cancer	0.000412	0.00154	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000411	0.00153	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Epirubicin—uterine cancer	0.00041	0.00153	CcSEcCtD
Nisoldipine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000409	0.00153	CcSEcCtD
Nisoldipine—Alopecia—Etoposide—uterine cancer	0.000406	0.00152	CcSEcCtD
Nisoldipine—Rash—Progesterone—uterine cancer	0.000402	0.0015	CcSEcCtD
Nisoldipine—Dermatitis—Progesterone—uterine cancer	0.000402	0.0015	CcSEcCtD
Nisoldipine—Headache—Progesterone—uterine cancer	0.0004	0.00149	CcSEcCtD
Nisoldipine—Increased appetite—Epirubicin—uterine cancer	0.000396	0.00148	CcSEcCtD
Nisoldipine—Diabetes mellitus—Doxorubicin—uterine cancer	0.000396	0.00148	CcSEcCtD
Nisoldipine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000395	0.00148	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000394	0.00147	CcSEcCtD
Nisoldipine—Decreased appetite—Dactinomycin—uterine cancer	0.000392	0.00146	CcSEcCtD
Nisoldipine—Dysgeusia—Etoposide—uterine cancer	0.000392	0.00146	CcSEcCtD
Nisoldipine—CACNA1C—smooth muscle tissue—uterine cancer	0.00039	0.0626	CbGeAlD
Nisoldipine—Muscle spasms—Etoposide—uterine cancer	0.000384	0.00144	CcSEcCtD
Nisoldipine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000382	0.00143	CcSEcCtD
Nisoldipine—CACNA1C—decidua—uterine cancer	0.000382	0.0613	CbGeAlD
Nisoldipine—Cerebrovascular accident—Epirubicin—uterine cancer	0.00038	0.00142	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00038	0.00142	CcSEcCtD
Nisoldipine—Nausea—Progesterone—uterine cancer	0.000379	0.00141	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000372	0.00139	CcSEcCtD
Nisoldipine—Feeling abnormal—Dactinomycin—uterine cancer	0.000372	0.00139	CcSEcCtD
Nisoldipine—Ill-defined disorder—Etoposide—uterine cancer	0.000371	0.00139	CcSEcCtD
Nisoldipine—Anaemia—Etoposide—uterine cancer	0.00037	0.00138	CcSEcCtD
Nisoldipine—Increased appetite—Doxorubicin—uterine cancer	0.000367	0.00137	CcSEcCtD
Nisoldipine—Migraine—Epirubicin—uterine cancer	0.000366	0.00137	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000365	0.00136	CcSEcCtD
Nisoldipine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000364	0.00136	CcSEcCtD
Nisoldipine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000364	0.00136	CcSEcCtD
Nisoldipine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000362	0.00135	CcSEcCtD
Nisoldipine—Malaise—Etoposide—uterine cancer	0.000361	0.00135	CcSEcCtD
Nisoldipine—Face oedema—Epirubicin—uterine cancer	0.000359	0.00134	CcSEcCtD
Nisoldipine—Vertigo—Etoposide—uterine cancer	0.000359	0.00134	CcSEcCtD
Nisoldipine—Leukopenia—Etoposide—uterine cancer	0.000358	0.00134	CcSEcCtD
Nisoldipine—Body temperature increased—Dactinomycin—uterine cancer	0.000356	0.00133	CcSEcCtD
Nisoldipine—Loss of consciousness—Etoposide—uterine cancer	0.000351	0.00131	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000351	0.00131	CcSEcCtD
Nisoldipine—Ataxia—Epirubicin—uterine cancer	0.00035	0.00131	CcSEcCtD
Nisoldipine—Cough—Etoposide—uterine cancer	0.000349	0.0013	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000344	0.00129	CcSEcCtD
Nisoldipine—Liver function test abnormal—Epirubicin—uterine cancer	0.000344	0.00128	CcSEcCtD
Nisoldipine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000343	0.00128	CcSEcCtD
Nisoldipine—Dry skin—Epirubicin—uterine cancer	0.000341	0.00127	CcSEcCtD
Nisoldipine—Chest pain—Etoposide—uterine cancer	0.00034	0.00127	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Epirubicin—uterine cancer	0.00034	0.00127	CcSEcCtD
Nisoldipine—Migraine—Doxorubicin—uterine cancer	0.000339	0.00127	CcSEcCtD
Nisoldipine—Hypokalaemia—Epirubicin—uterine cancer	0.000339	0.00126	CcSEcCtD
Nisoldipine—CACNB2—vagina—uterine cancer	0.000337	0.0541	CbGeAlD
Nisoldipine—Discomfort—Etoposide—uterine cancer	0.000336	0.00126	CcSEcCtD
Nisoldipine—Face oedema—Doxorubicin—uterine cancer	0.000332	0.00124	CcSEcCtD
Nisoldipine—Hypersensitivity—Dactinomycin—uterine cancer	0.000332	0.00124	CcSEcCtD
Nisoldipine—Gastritis—Epirubicin—uterine cancer	0.000329	0.00123	CcSEcCtD
Nisoldipine—Confusional state—Etoposide—uterine cancer	0.000329	0.00123	CcSEcCtD
Nisoldipine—Muscular weakness—Epirubicin—uterine cancer	0.000328	0.00123	CcSEcCtD
Nisoldipine—Ataxia—Doxorubicin—uterine cancer	0.000324	0.00121	CcSEcCtD
Nisoldipine—Asthma—Epirubicin—uterine cancer	0.000322	0.0012	CcSEcCtD
Nisoldipine—Influenza—Epirubicin—uterine cancer	0.000322	0.0012	CcSEcCtD
Nisoldipine—Dysphagia—Epirubicin—uterine cancer	0.000322	0.0012	CcSEcCtD
Nisoldipine—Tachycardia—Etoposide—uterine cancer	0.000318	0.00119	CcSEcCtD
Nisoldipine—CACNA2D1—female gonad—uterine cancer	0.000318	0.0511	CbGeAlD
Nisoldipine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000318	0.00119	CcSEcCtD
Nisoldipine—CACNA2D1—vagina—uterine cancer	0.000316	0.0508	CbGeAlD
Nisoldipine—Dry skin—Doxorubicin—uterine cancer	0.000316	0.00118	CcSEcCtD
Nisoldipine—Hyperhidrosis—Etoposide—uterine cancer	0.000315	0.00118	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000315	0.00117	CcSEcCtD
Nisoldipine—Hypokalaemia—Doxorubicin—uterine cancer	0.000313	0.00117	CcSEcCtD
Nisoldipine—Anorexia—Etoposide—uterine cancer	0.000311	0.00116	CcSEcCtD
Nisoldipine—Diarrhoea—Dactinomycin—uterine cancer	0.000308	0.00115	CcSEcCtD
Nisoldipine—Hypotension—Etoposide—uterine cancer	0.000305	0.00114	CcSEcCtD
Nisoldipine—Gastritis—Doxorubicin—uterine cancer	0.000305	0.00114	CcSEcCtD
Nisoldipine—Muscular weakness—Doxorubicin—uterine cancer	0.000304	0.00113	CcSEcCtD
Nisoldipine—Dysuria—Epirubicin—uterine cancer	0.000301	0.00112	CcSEcCtD
Nisoldipine—CACNA1C—female reproductive system—uterine cancer	0.0003	0.0482	CbGeAlD
Nisoldipine—Dysphagia—Doxorubicin—uterine cancer	0.000298	0.00111	CcSEcCtD
Nisoldipine—Asthma—Doxorubicin—uterine cancer	0.000298	0.00111	CcSEcCtD
Nisoldipine—Influenza—Doxorubicin—uterine cancer	0.000298	0.00111	CcSEcCtD
Nisoldipine—Pollakiuria—Epirubicin—uterine cancer	0.000297	0.00111	CcSEcCtD
Nisoldipine—Paraesthesia—Etoposide—uterine cancer	0.000293	0.00109	CcSEcCtD
Nisoldipine—Weight increased—Epirubicin—uterine cancer	0.000293	0.00109	CcSEcCtD
Nisoldipine—Weight decreased—Epirubicin—uterine cancer	0.000291	0.00109	CcSEcCtD
Nisoldipine—Dyspnoea—Etoposide—uterine cancer	0.000291	0.00109	CcSEcCtD
Nisoldipine—Somnolence—Etoposide—uterine cancer	0.00029	0.00108	CcSEcCtD
Nisoldipine—Rash—Dactinomycin—uterine cancer	0.000284	0.00106	CcSEcCtD
Nisoldipine—Decreased appetite—Etoposide—uterine cancer	0.000284	0.00106	CcSEcCtD
Nisoldipine—Stomatitis—Epirubicin—uterine cancer	0.00028	0.00104	CcSEcCtD
Nisoldipine—Conjunctivitis—Epirubicin—uterine cancer	0.000279	0.00104	CcSEcCtD
Nisoldipine—Dysuria—Doxorubicin—uterine cancer	0.000278	0.00104	CcSEcCtD
Nisoldipine—Sweating—Epirubicin—uterine cancer	0.000275	0.00103	CcSEcCtD
Nisoldipine—Pollakiuria—Doxorubicin—uterine cancer	0.000275	0.00103	CcSEcCtD
Nisoldipine—Haematuria—Epirubicin—uterine cancer	0.000273	0.00102	CcSEcCtD
Nisoldipine—CACNA1C—vagina—uterine cancer	0.000272	0.0436	CbGeAlD
Nisoldipine—Weight increased—Doxorubicin—uterine cancer	0.000271	0.00101	CcSEcCtD
Nisoldipine—Epistaxis—Epirubicin—uterine cancer	0.000271	0.00101	CcSEcCtD
Nisoldipine—Weight decreased—Doxorubicin—uterine cancer	0.000269	0.00101	CcSEcCtD
Nisoldipine—Sinusitis—Epirubicin—uterine cancer	0.000269	0.001	CcSEcCtD
Nisoldipine—Feeling abnormal—Etoposide—uterine cancer	0.000269	0.001	CcSEcCtD
Nisoldipine—Nausea—Dactinomycin—uterine cancer	0.000268	0.001	CcSEcCtD
Nisoldipine—Urticaria—Etoposide—uterine cancer	0.000259	0.000968	CcSEcCtD
Nisoldipine—Stomatitis—Doxorubicin—uterine cancer	0.000259	0.000966	CcSEcCtD
Nisoldipine—Rhinitis—Epirubicin—uterine cancer	0.000258	0.000964	CcSEcCtD
Nisoldipine—Body temperature increased—Etoposide—uterine cancer	0.000258	0.000963	CcSEcCtD
Nisoldipine—Conjunctivitis—Doxorubicin—uterine cancer	0.000258	0.000963	CcSEcCtD
Nisoldipine—Hypoaesthesia—Epirubicin—uterine cancer	0.000256	0.000956	CcSEcCtD
Nisoldipine—Pharyngitis—Epirubicin—uterine cancer	0.000256	0.000954	CcSEcCtD
Nisoldipine—Sweating—Doxorubicin—uterine cancer	0.000254	0.00095	CcSEcCtD
Nisoldipine—Oedema peripheral—Epirubicin—uterine cancer	0.000254	0.000947	CcSEcCtD
Nisoldipine—Haematuria—Doxorubicin—uterine cancer	0.000253	0.000945	CcSEcCtD
Nisoldipine—Epistaxis—Doxorubicin—uterine cancer	0.00025	0.000935	CcSEcCtD
Nisoldipine—Sinusitis—Doxorubicin—uterine cancer	0.000249	0.00093	CcSEcCtD
Nisoldipine—Visual impairment—Epirubicin—uterine cancer	0.000248	0.000926	CcSEcCtD
Nisoldipine—Hypersensitivity—Etoposide—uterine cancer	0.00024	0.000898	CcSEcCtD
Nisoldipine—Tinnitus—Epirubicin—uterine cancer	0.00024	0.000896	CcSEcCtD
Nisoldipine—Rhinitis—Doxorubicin—uterine cancer	0.000239	0.000892	CcSEcCtD
Nisoldipine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000237	0.000885	CcSEcCtD
Nisoldipine—Pharyngitis—Doxorubicin—uterine cancer	0.000236	0.000883	CcSEcCtD
Nisoldipine—Oedema peripheral—Doxorubicin—uterine cancer	0.000235	0.000876	CcSEcCtD
Nisoldipine—Chills—Epirubicin—uterine cancer	0.000231	0.000863	CcSEcCtD
Nisoldipine—Pruritus—Etoposide—uterine cancer	0.000231	0.000862	CcSEcCtD
Nisoldipine—Visual impairment—Doxorubicin—uterine cancer	0.00023	0.000857	CcSEcCtD
Nisoldipine—Alopecia—Epirubicin—uterine cancer	0.000228	0.000849	CcSEcCtD
Nisoldipine—Diarrhoea—Etoposide—uterine cancer	0.000223	0.000834	CcSEcCtD
Nisoldipine—Tinnitus—Doxorubicin—uterine cancer	0.000222	0.000829	CcSEcCtD
Nisoldipine—Flatulence—Epirubicin—uterine cancer	0.000221	0.000825	CcSEcCtD
Nisoldipine—Tension—Epirubicin—uterine cancer	0.00022	0.000821	CcSEcCtD
Nisoldipine—Dysgeusia—Epirubicin—uterine cancer	0.000219	0.000819	CcSEcCtD
Nisoldipine—CACNB2—lymph node—uterine cancer	0.000218	0.035	CbGeAlD
Nisoldipine—Nervousness—Epirubicin—uterine cancer	0.000218	0.000813	CcSEcCtD
Nisoldipine—Dizziness—Etoposide—uterine cancer	0.000216	0.000806	CcSEcCtD
Nisoldipine—Muscle spasms—Epirubicin—uterine cancer	0.000215	0.000805	CcSEcCtD
Nisoldipine—Chills—Doxorubicin—uterine cancer	0.000214	0.000798	CcSEcCtD
Nisoldipine—Alopecia—Doxorubicin—uterine cancer	0.000211	0.000786	CcSEcCtD
Nisoldipine—Ill-defined disorder—Epirubicin—uterine cancer	0.000208	0.000776	CcSEcCtD
Nisoldipine—Anaemia—Epirubicin—uterine cancer	0.000207	0.000773	CcSEcCtD
Nisoldipine—Rash—Etoposide—uterine cancer	0.000206	0.000768	CcSEcCtD
Nisoldipine—Dermatitis—Etoposide—uterine cancer	0.000206	0.000767	CcSEcCtD
Nisoldipine—CACNA2D1—lymph node—uterine cancer	0.000204	0.0328	CbGeAlD
Nisoldipine—Headache—Etoposide—uterine cancer	0.000204	0.000763	CcSEcCtD
Nisoldipine—Flatulence—Doxorubicin—uterine cancer	0.000204	0.000763	CcSEcCtD
Nisoldipine—Tension—Doxorubicin—uterine cancer	0.000204	0.00076	CcSEcCtD
Nisoldipine—Dysgeusia—Doxorubicin—uterine cancer	0.000203	0.000758	CcSEcCtD
Nisoldipine—Malaise—Epirubicin—uterine cancer	0.000202	0.000755	CcSEcCtD
Nisoldipine—Nervousness—Doxorubicin—uterine cancer	0.000201	0.000752	CcSEcCtD
Nisoldipine—Vertigo—Epirubicin—uterine cancer	0.000201	0.000752	CcSEcCtD
Nisoldipine—Syncope—Epirubicin—uterine cancer	0.000201	0.00075	CcSEcCtD
Nisoldipine—Leukopenia—Epirubicin—uterine cancer	0.000201	0.000749	CcSEcCtD
Nisoldipine—Muscle spasms—Doxorubicin—uterine cancer	0.000199	0.000744	CcSEcCtD
Nisoldipine—Palpitations—Epirubicin—uterine cancer	0.000198	0.000739	CcSEcCtD
Nisoldipine—CYP3A5—uterine cervix—uterine cancer	0.000197	0.0317	CbGeAlD
Nisoldipine—Loss of consciousness—Epirubicin—uterine cancer	0.000197	0.000735	CcSEcCtD
Nisoldipine—Cough—Epirubicin—uterine cancer	0.000196	0.00073	CcSEcCtD
Nisoldipine—Nausea—Etoposide—uterine cancer	0.000194	0.000724	CcSEcCtD
Nisoldipine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000192	0.000718	CcSEcCtD
Nisoldipine—Anaemia—Doxorubicin—uterine cancer	0.000192	0.000716	CcSEcCtD
Nisoldipine—CYP1A2—renal system—uterine cancer	0.000191	0.0307	CbGeAlD
Nisoldipine—Chest pain—Epirubicin—uterine cancer	0.000191	0.000712	CcSEcCtD
Nisoldipine—Arthralgia—Epirubicin—uterine cancer	0.000191	0.000712	CcSEcCtD
Nisoldipine—Myalgia—Epirubicin—uterine cancer	0.000191	0.000712	CcSEcCtD
Nisoldipine—CACNA1D—lymph node—uterine cancer	0.00019	0.0306	CbGeAlD
Nisoldipine—Anxiety—Epirubicin—uterine cancer	0.00019	0.00071	CcSEcCtD
Nisoldipine—Discomfort—Epirubicin—uterine cancer	0.000189	0.000704	CcSEcCtD
Nisoldipine—Malaise—Doxorubicin—uterine cancer	0.000187	0.000698	CcSEcCtD
Nisoldipine—Dry mouth—Epirubicin—uterine cancer	0.000187	0.000697	CcSEcCtD
Nisoldipine—Vertigo—Doxorubicin—uterine cancer	0.000186	0.000696	CcSEcCtD
Nisoldipine—Syncope—Doxorubicin—uterine cancer	0.000186	0.000694	CcSEcCtD
Nisoldipine—Leukopenia—Doxorubicin—uterine cancer	0.000186	0.000693	CcSEcCtD
Nisoldipine—CYP3A5—renal system—uterine cancer	0.000185	0.0296	CbGeAlD
Nisoldipine—Confusional state—Epirubicin—uterine cancer	0.000184	0.000689	CcSEcCtD
Nisoldipine—Palpitations—Doxorubicin—uterine cancer	0.000183	0.000684	CcSEcCtD
Nisoldipine—Oedema—Epirubicin—uterine cancer	0.000183	0.000683	CcSEcCtD
Nisoldipine—Loss of consciousness—Doxorubicin—uterine cancer	0.000182	0.000681	CcSEcCtD
Nisoldipine—Cough—Doxorubicin—uterine cancer	0.000181	0.000676	CcSEcCtD
Nisoldipine—Shock—Epirubicin—uterine cancer	0.00018	0.000672	CcSEcCtD
Nisoldipine—Tachycardia—Epirubicin—uterine cancer	0.000179	0.000667	CcSEcCtD
Nisoldipine—Hyperhidrosis—Epirubicin—uterine cancer	0.000177	0.00066	CcSEcCtD
Nisoldipine—Arthralgia—Doxorubicin—uterine cancer	0.000177	0.000659	CcSEcCtD
Nisoldipine—Myalgia—Doxorubicin—uterine cancer	0.000177	0.000659	CcSEcCtD
Nisoldipine—Chest pain—Doxorubicin—uterine cancer	0.000177	0.000659	CcSEcCtD
Nisoldipine—Anxiety—Doxorubicin—uterine cancer	0.000176	0.000657	CcSEcCtD
Nisoldipine—CACNA1C—lymph node—uterine cancer	0.000176	0.0282	CbGeAlD
Nisoldipine—Discomfort—Doxorubicin—uterine cancer	0.000174	0.000651	CcSEcCtD
Nisoldipine—Anorexia—Epirubicin—uterine cancer	0.000174	0.000651	CcSEcCtD
Nisoldipine—Dry mouth—Doxorubicin—uterine cancer	0.000173	0.000645	CcSEcCtD
Nisoldipine—Hypotension—Epirubicin—uterine cancer	0.000171	0.000638	CcSEcCtD
Nisoldipine—Confusional state—Doxorubicin—uterine cancer	0.000171	0.000637	CcSEcCtD
Nisoldipine—Oedema—Doxorubicin—uterine cancer	0.000169	0.000632	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000167	0.000622	CcSEcCtD
Nisoldipine—Shock—Doxorubicin—uterine cancer	0.000167	0.000622	CcSEcCtD
Nisoldipine—Insomnia—Epirubicin—uterine cancer	0.000165	0.000618	CcSEcCtD
Nisoldipine—Tachycardia—Doxorubicin—uterine cancer	0.000165	0.000617	CcSEcCtD
Nisoldipine—Paraesthesia—Epirubicin—uterine cancer	0.000164	0.000613	CcSEcCtD
Nisoldipine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000164	0.000611	CcSEcCtD
Nisoldipine—Dyspnoea—Epirubicin—uterine cancer	0.000163	0.000609	CcSEcCtD
Nisoldipine—Somnolence—Epirubicin—uterine cancer	0.000163	0.000607	CcSEcCtD
Nisoldipine—Anorexia—Doxorubicin—uterine cancer	0.000161	0.000602	CcSEcCtD
Nisoldipine—Dyspepsia—Epirubicin—uterine cancer	0.000161	0.000601	CcSEcCtD
Nisoldipine—Decreased appetite—Epirubicin—uterine cancer	0.000159	0.000594	CcSEcCtD
Nisoldipine—Hypotension—Doxorubicin—uterine cancer	0.000158	0.00059	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000154	0.000576	CcSEcCtD
Nisoldipine—Insomnia—Doxorubicin—uterine cancer	0.000153	0.000572	CcSEcCtD
Nisoldipine—Paraesthesia—Doxorubicin—uterine cancer	0.000152	0.000567	CcSEcCtD
Nisoldipine—Dyspnoea—Doxorubicin—uterine cancer	0.000151	0.000563	CcSEcCtD
Nisoldipine—Feeling abnormal—Epirubicin—uterine cancer	0.000151	0.000563	CcSEcCtD
Nisoldipine—Somnolence—Doxorubicin—uterine cancer	0.00015	0.000562	CcSEcCtD
Nisoldipine—Dyspepsia—Doxorubicin—uterine cancer	0.000149	0.000556	CcSEcCtD
Nisoldipine—Decreased appetite—Doxorubicin—uterine cancer	0.000147	0.000549	CcSEcCtD
Nisoldipine—Urticaria—Epirubicin—uterine cancer	0.000145	0.000543	CcSEcCtD
Nisoldipine—Body temperature increased—Epirubicin—uterine cancer	0.000145	0.00054	CcSEcCtD
Nisoldipine—Feeling abnormal—Doxorubicin—uterine cancer	0.000139	0.000521	CcSEcCtD
Nisoldipine—CYP3A4—renal system—uterine cancer	0.000138	0.0222	CbGeAlD
Nisoldipine—Hypersensitivity—Epirubicin—uterine cancer	0.000135	0.000503	CcSEcCtD
Nisoldipine—ABCB1—myometrium—uterine cancer	0.000135	0.0216	CbGeAlD
Nisoldipine—Urticaria—Doxorubicin—uterine cancer	0.000134	0.000502	CcSEcCtD
Nisoldipine—CYP3A5—female gonad—uterine cancer	0.000134	0.0216	CbGeAlD
Nisoldipine—Body temperature increased—Doxorubicin—uterine cancer	0.000134	0.0005	CcSEcCtD
Nisoldipine—CYP3A5—vagina—uterine cancer	0.000134	0.0215	CbGeAlD
Nisoldipine—Pruritus—Epirubicin—uterine cancer	0.000129	0.000483	CcSEcCtD
Nisoldipine—Diarrhoea—Epirubicin—uterine cancer	0.000125	0.000467	CcSEcCtD
Nisoldipine—Hypersensitivity—Doxorubicin—uterine cancer	0.000125	0.000466	CcSEcCtD
Nisoldipine—Dizziness—Epirubicin—uterine cancer	0.000121	0.000452	CcSEcCtD
Nisoldipine—Pruritus—Doxorubicin—uterine cancer	0.00012	0.000447	CcSEcCtD
Nisoldipine—Diarrhoea—Doxorubicin—uterine cancer	0.000116	0.000432	CcSEcCtD
Nisoldipine—Rash—Epirubicin—uterine cancer	0.000115	0.000431	CcSEcCtD
Nisoldipine—Dermatitis—Epirubicin—uterine cancer	0.000115	0.00043	CcSEcCtD
Nisoldipine—Headache—Epirubicin—uterine cancer	0.000115	0.000428	CcSEcCtD
Nisoldipine—Dizziness—Doxorubicin—uterine cancer	0.000112	0.000418	CcSEcCtD
Nisoldipine—CYP3A4—female reproductive system—uterine cancer	0.000111	0.0178	CbGeAlD
Nisoldipine—Nausea—Epirubicin—uterine cancer	0.000109	0.000406	CcSEcCtD
Nisoldipine—Rash—Doxorubicin—uterine cancer	0.000107	0.000398	CcSEcCtD
Nisoldipine—Dermatitis—Doxorubicin—uterine cancer	0.000107	0.000398	CcSEcCtD
Nisoldipine—Headache—Doxorubicin—uterine cancer	0.000106	0.000396	CcSEcCtD
Nisoldipine—ABCB1—epithelium—uterine cancer	0.000106	0.017	CbGeAlD
Nisoldipine—ABCB1—uterine cervix—uterine cancer	0.000105	0.0168	CbGeAlD
Nisoldipine—Nausea—Doxorubicin—uterine cancer	0.000101	0.000375	CcSEcCtD
Nisoldipine—ABCB1—decidua—uterine cancer	9.98e-05	0.016	CbGeAlD
Nisoldipine—ABCB1—renal system—uterine cancer	9.8e-05	0.0157	CbGeAlD
Nisoldipine—ABCB1—endometrium—uterine cancer	9.48e-05	0.0152	CbGeAlD
Nisoldipine—ABCB1—mammalian vulva—uterine cancer	9.17e-05	0.0147	CbGeAlD
Nisoldipine—ABCB1—uterus—uterine cancer	8.73e-05	0.014	CbGeAlD
Nisoldipine—ABCB1—female reproductive system—uterine cancer	7.85e-05	0.0126	CbGeAlD
Nisoldipine—ABCB1—female gonad—uterine cancer	7.14e-05	0.0115	CbGeAlD
Nisoldipine—ABCB1—vagina—uterine cancer	7.1e-05	0.0114	CbGeAlD
Nisoldipine—CACNB2—Metabolism—STAR—uterine cancer	5.1e-05	0.00274	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	5.04e-05	0.0027	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MET—uterine cancer	5.02e-05	0.0027	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	4.84e-05	0.00259	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—STAR—uterine cancer	4.83e-05	0.00259	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—AKR1B1—uterine cancer	4.83e-05	0.00259	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	4.79e-05	0.00257	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	4.77e-05	0.00256	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—SMAD3—uterine cancer	4.62e-05	0.00248	CbGpPWpGaD
Nisoldipine—ABCB1—lymph node—uterine cancer	4.59e-05	0.00738	CbGeAlD
Nisoldipine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	4.52e-05	0.00243	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—ERBB2—uterine cancer	4.52e-05	0.00243	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MET—uterine cancer	4.42e-05	0.00237	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MET—uterine cancer	4.41e-05	0.00237	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—SMAD3—uterine cancer	4.37e-05	0.00235	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—STAR—uterine cancer	4.24e-05	0.00228	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—AKR1B1—uterine cancer	4.24e-05	0.00228	CbGpPWpGaD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.23e-05	0.00227	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	4.21e-05	0.00226	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—POLD1—uterine cancer	4e-05	0.00215	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.99e-05	0.00214	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	3.96e-05	0.00212	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	3.9e-05	0.00209	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—ERBB2—uterine cancer	3.88e-05	0.00208	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—SMAD3—uterine cancer	3.84e-05	0.00206	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	3.8e-05	0.00204	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.8e-05	0.00204	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—POLD1—uterine cancer	3.79e-05	0.00203	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MET—uterine cancer	3.79e-05	0.00203	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—AKR1C1—uterine cancer	3.74e-05	0.00201	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.7e-05	0.00198	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.69e-05	0.00198	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	3.69e-05	0.00198	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—ERBB2—uterine cancer	3.67e-05	0.00197	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—SRD5A2—uterine cancer	3.59e-05	0.00193	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NDUFB11—uterine cancer	3.59e-05	0.00193	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MET—uterine cancer	3.59e-05	0.00192	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—AKR1C1—uterine cancer	3.54e-05	0.0019	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.51e-05	0.00189	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—VEGFA—uterine cancer	3.48e-05	0.00187	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—NRAS—uterine cancer	3.44e-05	0.00185	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.36e-05	0.0018	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—RRM2—uterine cancer	3.34e-05	0.00179	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	3.34e-05	0.00179	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.34e-05	0.00179	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—POLD1—uterine cancer	3.33e-05	0.00179	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.25e-05	0.00174	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—DCN—uterine cancer	3.24e-05	0.00174	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—ERBB2—uterine cancer	3.23e-05	0.00173	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—ERBB2—uterine cancer	3.23e-05	0.00173	CbGpPWpGaD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—HRAS—uterine cancer	3.17e-05	0.0017	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CXCL8—uterine cancer	3.16e-05	0.0017	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—RRM2—uterine cancer	3.16e-05	0.00169	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.16e-05	0.00169	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MET—uterine cancer	3.15e-05	0.00169	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.13e-05	0.00168	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.12e-05	0.00167	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—AKR1C1—uterine cancer	3.11e-05	0.00167	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—DCN—uterine cancer	3.07e-05	0.00165	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.06e-05	0.00164	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP11A1—uterine cancer	3.05e-05	0.00164	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.03e-05	0.00162	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.01e-05	0.00162	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.01e-05	0.00161	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—VEGFA—uterine cancer	2.99e-05	0.0016	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.96e-05	0.00159	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—KRAS—uterine cancer	2.96e-05	0.00159	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—NRAS—uterine cancer	2.95e-05	0.00158	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.91e-05	0.00156	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP11A1—uterine cancer	2.89e-05	0.00155	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—AKR1C3—uterine cancer	2.88e-05	0.00155	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.87e-05	0.00154	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.85e-05	0.00153	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—VEGFA—uterine cancer	2.83e-05	0.00152	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—CTNNB1—uterine cancer	2.82e-05	0.00151	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—NRAS—uterine cancer	2.79e-05	0.0015	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—RRM2—uterine cancer	2.78e-05	0.00149	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—ERBB2—uterine cancer	2.77e-05	0.00148	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—AKR1C3—uterine cancer	2.73e-05	0.00146	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—DCN—uterine cancer	2.7e-05	0.00145	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.69e-05	0.00144	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—EP300—uterine cancer	2.62e-05	0.00141	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—ERBB2—uterine cancer	2.62e-05	0.00141	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—AKR1B1—uterine cancer	2.6e-05	0.00139	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—STAR—uterine cancer	2.6e-05	0.00139	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NDUFB11—uterine cancer	2.6e-05	0.00139	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—SRD5A2—uterine cancer	2.6e-05	0.00139	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.57e-05	0.00138	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.54e-05	0.00136	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.54e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—KRAS—uterine cancer	2.54e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP11A1—uterine cancer	2.54e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—HRAS—uterine cancer	2.52e-05	0.00135	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—VEGFA—uterine cancer	2.49e-05	0.00133	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—VEGFA—uterine cancer	2.49e-05	0.00133	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—NRAS—uterine cancer	2.46e-05	0.00132	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—NRAS—uterine cancer	2.45e-05	0.00132	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—HRAS—uterine cancer	2.43e-05	0.0013	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—CTNNB1—uterine cancer	2.42e-05	0.0013	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—KRAS—uterine cancer	2.4e-05	0.00129	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—AKR1C3—uterine cancer	2.4e-05	0.00129	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—ERBB2—uterine cancer	2.3e-05	0.00124	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—CTNNB1—uterine cancer	2.29e-05	0.00123	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.28e-05	0.00122	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—EP300—uterine cancer	2.25e-05	0.00121	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.25e-05	0.00121	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—STK11—uterine cancer	2.24e-05	0.0012	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP19A1—uterine cancer	2.24e-05	0.0012	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.24e-05	0.0012	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.22e-05	0.00119	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—HRAS—uterine cancer	2.16e-05	0.00116	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—VEGFA—uterine cancer	2.13e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—EP300—uterine cancer	2.13e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—STK11—uterine cancer	2.13e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP19A1—uterine cancer	2.13e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—KRAS—uterine cancer	2.11e-05	0.00113	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—KRAS—uterine cancer	2.11e-05	0.00113	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—NRAS—uterine cancer	2.11e-05	0.00113	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—HRAS—uterine cancer	2.04e-05	0.0011	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—POLD1—uterine cancer	2.04e-05	0.00109	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—VEGFA—uterine cancer	2.02e-05	0.00108	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—CTNNB1—uterine cancer	2.01e-05	0.00108	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—NRAS—uterine cancer	1.99e-05	0.00107	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NDUFB11—uterine cancer	1.96e-05	0.00105	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—SRD5A2—uterine cancer	1.96e-05	0.00105	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—AKR1C1—uterine cancer	1.91e-05	0.00102	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.89e-05	0.00101	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.88e-05	0.00101	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—STAR—uterine cancer	1.88e-05	0.00101	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—EP300—uterine cancer	1.87e-05	0.001	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP19A1—uterine cancer	1.87e-05	0.001	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—STK11—uterine cancer	1.87e-05	0.001	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.86e-05	0.001	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—KRAS—uterine cancer	1.81e-05	0.000972	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—HRAS—uterine cancer	1.8e-05	0.000964	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—HRAS—uterine cancer	1.8e-05	0.000963	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—VEGFA—uterine cancer	1.77e-05	0.000951	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—NRAS—uterine cancer	1.75e-05	0.00094	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—KRAS—uterine cancer	1.72e-05	0.00092	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—RRM2—uterine cancer	1.7e-05	0.000912	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—MTHFR—uterine cancer	1.69e-05	0.000905	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—DCN—uterine cancer	1.65e-05	0.000885	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.64e-05	0.000882	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—MTHFR—uterine cancer	1.6e-05	0.000857	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—AKT1—uterine cancer	1.59e-05	0.000851	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.57e-05	0.00084	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.57e-05	0.00084	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP11A1—uterine cancer	1.55e-05	0.000834	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—HRAS—uterine cancer	1.54e-05	0.000826	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.52e-05	0.000817	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.52e-05	0.000816	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—KRAS—uterine cancer	1.51e-05	0.000809	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—POLD1—uterine cancer	1.47e-05	0.000791	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.47e-05	0.000788	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—HRAS—uterine cancer	1.46e-05	0.000782	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.44e-05	0.000772	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.44e-05	0.00077	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AKR1B1—uterine cancer	1.42e-05	0.00076	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—STAR—uterine cancer	1.42e-05	0.00076	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—MTHFR—uterine cancer	1.4e-05	0.000753	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.4e-05	0.000752	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.38e-05	0.00074	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—AKT1—uterine cancer	1.36e-05	0.00073	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.34e-05	0.000718	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—AKT1—uterine cancer	1.29e-05	0.000691	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—HRAS—uterine cancer	1.28e-05	0.000687	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.27e-05	0.00068	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—RRM2—uterine cancer	1.23e-05	0.000659	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.21e-05	0.000648	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.21e-05	0.000648	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—DCN—uterine cancer	1.19e-05	0.00064	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—STK11—uterine cancer	1.14e-05	0.000614	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.14e-05	0.000614	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—AKT1—uterine cancer	1.13e-05	0.000607	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.13e-05	0.000607	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—STAR—uterine cancer	1.13e-05	0.000607	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.12e-05	0.000603	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.12e-05	0.0006	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—POLD1—uterine cancer	1.11e-05	0.000597	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.08e-05	0.000578	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.000569	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AKR1C1—uterine cancer	1.04e-05	0.000558	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.89e-06	0.000531	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	9.57e-06	0.000514	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTEN—uterine cancer	9.39e-06	0.000503	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—RRM2—uterine cancer	9.27e-06	0.000497	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—DCN—uterine cancer	9e-06	0.000483	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—EP300—uterine cancer	8.95e-06	0.00048	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTEN—uterine cancer	8.89e-06	0.000477	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—POLD1—uterine cancer	8.88e-06	0.000476	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—STAR—uterine cancer	8.73e-06	0.000468	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AKR1B1—uterine cancer	8.73e-06	0.000468	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—MTHFR—uterine cancer	8.6e-06	0.000461	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP11A1—uterine cancer	8.48e-06	0.000455	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—EP300—uterine cancer	8.48e-06	0.000455	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AKR1C1—uterine cancer	8.31e-06	0.000446	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—STK11—uterine cancer	8.27e-06	0.000444	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP19A1—uterine cancer	8.27e-06	0.000444	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	8.08e-06	0.000434	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AKR1C3—uterine cancer	8.01e-06	0.00043	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTEN—uterine cancer	7.81e-06	0.000419	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—EP300—uterine cancer	7.45e-06	0.0004	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—RRM2—uterine cancer	7.4e-06	0.000397	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—DCN—uterine cancer	7.19e-06	0.000386	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—POLD1—uterine cancer	6.85e-06	0.000368	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.77e-06	0.000363	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PIK3CA—uterine cancer	6.62e-06	0.000355	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.41e-06	0.000344	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.39e-06	0.000343	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PIK3CA—uterine cancer	6.27e-06	0.000336	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP19A1—uterine cancer	6.24e-06	0.000335	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—STK11—uterine cancer	6.24e-06	0.000335	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—MTHFR—uterine cancer	6.21e-06	0.000333	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—RRM2—uterine cancer	5.71e-06	0.000306	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—DCN—uterine cancer	5.55e-06	0.000298	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PIK3CA—uterine cancer	5.51e-06	0.000296	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—AKT1—uterine cancer	5.41e-06	0.00029	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.23e-06	0.00028	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—AKT1—uterine cancer	5.12e-06	0.000275	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—STK11—uterine cancer	4.98e-06	0.000267	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.98e-06	0.000267	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.93e-06	0.000265	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTEN—uterine cancer	4.78e-06	0.000257	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—MTHFR—uterine cancer	4.69e-06	0.000252	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.68e-06	0.000251	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—EP300—uterine cancer	4.56e-06	0.000245	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—AKT1—uterine cancer	4.5e-06	0.000241	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.46e-06	0.000239	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—STK11—uterine cancer	3.84e-06	0.000206	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.84e-06	0.000206	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—MTHFR—uterine cancer	3.74e-06	0.000201	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTEN—uterine cancer	3.46e-06	0.000185	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PIK3CA—uterine cancer	3.37e-06	0.000181	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.3e-06	0.000177	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—EP300—uterine cancer	3.3e-06	0.000177	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—MTHFR—uterine cancer	2.89e-06	0.000155	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—AKT1—uterine cancer	2.76e-06	0.000148	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTEN—uterine cancer	2.61e-06	0.00014	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—EP300—uterine cancer	2.49e-06	0.000133	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.44e-06	0.000131	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTEN—uterine cancer	2.08e-06	0.000112	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—AKT1—uterine cancer	1.99e-06	0.000107	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—EP300—uterine cancer	1.99e-06	0.000107	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PIK3CA—uterine cancer	1.84e-06	9.87e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTEN—uterine cancer	1.61e-06	8.62e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—EP300—uterine cancer	1.53e-06	8.22e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AKT1—uterine cancer	1.5e-06	8.06e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.47e-06	7.88e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AKT1—uterine cancer	1.2e-06	6.44e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.13e-06	6.08e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AKT1—uterine cancer	9.26e-07	4.97e-05	CbGpPWpGaD
